Security key
75886F107
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 92,759,471
- Total 13F value
- $89,156,855,451
- Share change
- +2,597,938
- Put/Call ratio
- 176%
- SEC-reported price per share
- $962.49
- Number of holders
- 1,301
- Value change
- +$2,508,878,899
- Number of buys
- 606
- Number of sells
- 541
- Shares outstanding
- 103,945,862
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
1,301
Top holders
10
REGN full security history
Ownership snapshot
Full 13F holder table
REGENERON PHARMACEUTICALS, INC. SEC filings
REGENERON PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $9,061,682,469
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $9.06B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$9.06B
VANGUARD GROUP INC
$7.76B
BlackRock Finance, Inc.
$7.58B
JPMORGAN CHASE & CO
$6.35B
Capital World Investors
$4.51B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$9,061,682,469
10,317,415 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$7,762,577,333
8,838,285 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$7,579,385,538
8,629,707 shares
|
— | 31 Dec 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$6,347,199,734
7,226,769 shares
|
— | 31 Dec 2023 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$4,506,070,906
5,130,485 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$4,304,719,741
4,901,251 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,301
Shares
92,759,471
Rows available
1,301
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
1,301
Q1 2024 holders
1,301
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|